WAVEMAN · COMPANY

GLAS · Glass House Brands Inc.

LIVE

TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV-1.12% 13F +693CRM-0.46% 13F +1,018CVNA+2.74% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+15.81% 13F +1,203CRWD-5.42% 13F +1,382ANET+2.87% 13F +1,323COIN-1.05% 13F +475TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV-1.12% 13F +693CRM-0.46% 13F +1,018CVNA+2.74% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+15.81% 13F +1,203CRWD-5.42% 13F +1,382ANET+2.87% 13F +1,323COIN-1.05% 13F +475

← ALL COMPANIES

GLAS

Name: Glass House Brands Inc. (GLAS) insider trading and ownership data
Creator: WaveMan
License: https://wave-man.com/terms

Glass House Brands Inc.

PHARMA & BIOTECH · MEDICINAL CHEMICALS & BOTANICAL PRODUCTS · CIK 0001848731

FORM 144 · 1☆ WATCH

INSIDER NET · 180D

open-market buys minus sells, Form 4 codes P and S

INSIDER BUYERS · 180D

CONGRESS BUYERS · 1Y

FUNDS ADDED · QTR

13F, latest reported quarter

REVENUE GROWTH

-9.4%

XBRL, annual

NET MARGIN

-16.3%

SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST

INSIDERS

no Form 4 purchases or sales on file

CONGRESS

no member of Congress has reported trading it

FUNDS

51 funds added or opened last quarter

below 55% of Pharma & Biotech

REVENUE

-9.4% year over year

below 70% of Pharma & Biotech

MARGIN

-16.3% net margin

more than 52% of Pharma & Biotech

BUYBACKS

no share repurchases reported

SHORT

1.0 days to cover · settled 2026-07-31

THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET

51 funds added or opened positions in the latest 13F quarter, of 53 holders.

Live price

Daily candles from TradingView, on their licence — no filings are marked on this one

WHY THIS NAME IS ON THE DESK

Insiders have filed to sell — before selling.

The record shows 51 funds added last quarter, $416.0K in planned Form 144 sales. Every figure is a federal filing, dated the day it became public.

Backtest this pattern Open the screener

Same sector, ranked by filing activity

Sector from the SEC's own SIC classification

UTHR CPIX MRNA REGN LLY ALNY ELF CITR MDGL DNA VRTX NUVL

Insider transactions

Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

No insider purchases or sales are on record for Glass House Brands Inc. in the period covered. Source: SEC Form 4 filings, as of 2026-09-04.

INSIDER

FILED

VALUE

no insider purchases or sales on record

0 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see the full history, the screener and CSV export, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders

13F · holdings as of the latest quarter funds have reported

Park West Asset Management LLC

5,182,030.0 sh

$67.4M

Western Standard LLC

2,728,768.0 sh

$35.0M

CANTOR FITZGERALD, L. P.

2,700,000.0 sh

$33.3M

NOMURA HOLDINGS INC

2,283,439.0 sh

$29.7M

WELLINGTON MANAGEMENT GROUP LLP

1,145,088.0 sh

$14.9M

SCHEDULE 13D/G

No 5%+ ownership filings

Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.

Planned sales · Form 144

Filed before the sale — intent, not a trade

Kyle Kazan

FILED 2026-08-28

$416.0K

Fundamentals

Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all

	2025-12	2024-12	2023-12	2022-12
REVENUE	$182.0M	$200.9M	$160.8M	$84.9M
GROSS PROFIT	$77.0M	$97.4M	$81.0M	$20.7M
OPERATING INCOME	$-16.5M	$5.7M	$-49.5M	$-56.4M
NET INCOME	$-29.7M	$519.0K	$-98.3M	$-32.9M
EPS (DILUTED)	-0.55	-0.21	-1.62	-0.83
OPERATING CASH FLOW	$11.4M	$28.4M	$23.2M	$-40.8M
LONG-TERM DEBT	$68.6M	$50.6M	$56.5M	$62.6M

SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-04 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE